Schedule 13G ownership disclosure
Apellis Pharmaceuticals Inc
Security class unavailable · CUSIP: 03753U106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,865,712
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000834237-22-006303
- Form type
- SC 13G
- Filer
- Apellis Pharmaceuticals, Inc.
- CIK
- CIK 1492422
- Filed
- Feb 03, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership